Back
Credo Technology Group Holding Ltd. 10K Form
Buy
95
CRDO
Credo Technology Group Holding Ltd.
Last Price:
$180.91
Seasonality Move:
-6.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRDO News And Ratings
See the #1 stock for the next 7 days that we like better than CRDO
CRDO Financial Statistics
Sales & Book Value
| Annual Sales: | $436.8M |
|---|---|
| Cash Flow: | $38.5M |
| Price / Cash Flow: | 242.67 |
| Annual Sales: | $7.20 |
| Price / Book: | 26.57 |
Profitability
| EPS (TTM): | 1.14570 |
|---|---|
| Net Income (TTM): | $212M |
| Gross Margin: | $282.9M |
| Return on Equity: | 26.93% |
| Return on Assets: | 23.44% |
Credo Technology Group Holding Ltd. Earnings Forecast
Key Credo Technology Group Holding Ltd. Financial Ratios
-
The Gross Profit Margin over the past 6 years for CRDO is 64.77%.
-
The Selling, General & Administrative Expenses for CRDO have been equal to 22.65% of Gross Profit Margin.
-
The Research & Development expenses have been 33.43% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of CRDO is 11.95% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Credo Technology Group Holding Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | CRDO |
| Website: | credosemi.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 8.86 |
| Quick Ratio: | 7.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 656.91 |
|---|---|
| Forward P/E Ratio: | 52.02 |
CRDO Technical Analysis vs Fundamental Analysis
Buy
95
Credo Technology Group Holding Ltd. (CRDO)
is a Buy
Is Credo Technology Group Holding Ltd. a Buy or a Sell?
-
Credo Technology Group Holding Ltd. stock is rated a BuyThe current Credo Technology Group Holding Ltd. [CRDO] share price is $189.19. The Score for CRDO is 95, which is 90% above its historic median score of 50, and infers lower risk than normal.